CPET and Outcome After Oesophagogastric Cancer Surgery
Cardiopulmonary Exercise Variables Are Associated With Postoperative Morbidity and Mortality After Major Oesophagogastric Cancer Surgery - A Multicentre Observational Study
1 other identifier
observational
611
1 country
1
Brief Summary
Primary Aim: The present study is a retrospective analysis of prospectively collected clinical data. Anonymized data from patients collected during routine clinical care from 9 units in the United Kingdom who undertake upper gastrointestinal (UGI) cancer surgery and perform pre-operative cardiopulmonary exercise testing will be interrogated. Data will be pooled at a central location (University Hospitals Southampton) and used to investigate the relationship between selected cardiopulmonary exercise testing (CPET) variables, in-hospital post-operative and survival outcomes after major UGI cancer surgery. Rationale: Our primary aim is to establish a reliable relationship between post-operative survival (1 and 3 -year) and oxygen uptake (VO2) at peak exercise (VO2 Peak); a secondary aim is to explore the multivariable relationship between selected CPET variables especially VO2 at the estimated lactate threshold/anaerobic threshold (AT), together with other selected CPET derived variables, and other important prognostic variables with post-operative complications (morbidity and mortality) in an attempt to risk stratify patients before major UGI surgery. Trial Design: Multicentre observational Inclusion Criteria: We aim to include all patients aged \>18 years considered eligible by the MDT for major curative UGI cancer surgery and undergoing an enhanced recovery programme after surgery. Patients undergoing neoadjuvant chemotherapy or chemoradiotherapies will also be included. Patients having a CPET and initially scheduled for curative surgery, but end up not having surgery due to disease progression or other clinical reasons will be included and analysed separately. Exclusion Criteria: Patients will be excluded if they are physically unable to perform a CPET on a cycle ergometer, patients having emergency surgery, patients lacking complete in-hospital morbidity or mortality data and patients undergoing preoperative exercise interventions. Primary Trial Endpoints: 3 year overall survival
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 10, 2018
CompletedFirst Posted
Study publicly available on registry
August 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedApril 13, 2022
March 1, 2022
8.6 years
August 10, 2018
April 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fitness
Oxygen uptake at estimated lactate threshold
up to 4 weeks before pre-surgery
Secondary Outcomes (1)
Sarcopenia defined by skeletal muscle radiation attenuation
up to 4 weeks before pre-surgery
Study Arms (1)
Upper gastrointestinal cancer
Upper gastrointestinal cancers including oesophagus and stomach
Interventions
The CPET involves cycling on an exercise bike for 8-12 minutes. Starting with a very low resistance on the pedals the patient will pedal at 60 revolutions per minute. After 3 minutes of cycling, the resistance will gradually increase until the patient can no longer turn the pedals at the required speed. The test will be thoroughly explained to the patient beforehand and trained staff will make the experience as comfortable as possible. CPETs will be stopped early by the study researcher/doctor in the presence of any adverse events. Each CPET appointment will last approximately one hour.
Eligibility Criteria
Upper gastrointestinal cancer patients
You may qualify if:
- We aim to include all patients aged \>18 years considered eligible by the MDT for major curative UGI cancer surgery
- undergoing an enhanced recovery programme after surgery.
- Patients undergoing neoadjuvant chemotherapy or chemoradiotherapies will also be included.
- Patients having a CPET and initially scheduled for curative surgery, but end up not having surgery due to disease progression or other clinical reasons will be included and analysed separately.
You may not qualify if:
- physically unable to perform a CPET on a cycle ergometer,
- patients having emergency surgery,
- patients lacking complete in-hospital morbidity or mortality data and patients undergoing preoperative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Southampton NHS Foundation Trustlead
- Royal Surrey County Hospital NHS Foundation Trustcollaborator
- Sheffield Teaching Hospitals NHS Foundation Trustcollaborator
- South Tees Hospitals NHS Foundation Trustcollaborator
- University Hospital Plymouth NHS Trustcollaborator
- Lancashire Teaching Hospitals NHS Foundation Trustcollaborator
- Liverpool University Hospitals NHS Foundation Trustcollaborator
- University Hospitals, Leicestercollaborator
- Oxford University Hospitals NHS Trustcollaborator
Study Sites (1)
University Hospitals Southampton
Southampton, United Kingdom
Related Publications (1)
West MA, Rahman S, Jack S, Grocott MPW, Levett DZH; Perioperative Exercise Testing and Training Society (POETTS); Rashid Y, Griffiths J, Ezra M, Ayres L, Neville-Webbe H, Javed MS, Shrotri M, Khan I, Whitmore D, Prabhu P, Timbrell D, Allen S, Packham AO, Sharpe D, Anderson H, Minto G, McAleer S, McPhail S, Alasmar M, Hartley RA, Sultan J, Grace B, Underwood TJ, Byrne J, Noble F, Kelly J, Ansell G, Edwards M. Cardiopulmonary exercise variables and their association with postoperative morbidity and mortality after major oesophagogastric cancer surgery-a multicentre observational study. BJA Open. 2024 Jun 7;10:100289. doi: 10.1016/j.bjao.2024.100289. eCollection 2024 Jun.
PMID: 38947220DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denny Levett, PhD
University Hospitals Southampton NHS Foundation Trust
- PRINCIPAL INVESTIGATOR
Malcolm West, PhD
University Hospitals Southampton NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2018
First Posted
August 20, 2018
Study Start
June 1, 2012
Primary Completion
January 1, 2021
Study Completion
March 1, 2022
Last Updated
April 13, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
No plan exists for individual participant data to be shared